Company Qiagen Gdańsk
Qiagen Gdańsk
KRSCompany age:
Age:
2 y. 5 m. 15 d.
Share capital:
Share capital:
1 752 650 PLN
Company information
Management
Beneficiaries (3)
Legal entity history
Patents (2)
Legal Entity Identifier (LEI)
KRS
0001053182
NIP
5833009329
REGON
22052789500000
| Address | UL. TRZY LIPY 3-2.58, PL-80-172, GDAŃSK | |
| Voivodeship | Pomeranian |
Add to phone
Scan the QR code to add the company’s contact details directly to your phone.
Management
Bernard Thierry Laurent, prezes zarządu
Other management members ›
Beneficiaries of
3 beneficiaries
More ›
| Rating | |||
| Main industry | Research and experimental development on biotechnology | ||
| Account number |
PL81 1750 1325 0000 0000 3916 5864
PL04 1750 1325 0000 0000 2744 1017
PL22 1750 1325 0000 0000 1285 4706
PL47 1750 1325 0000 0000 2106 6567 PL69 1750 1325 0000 0000 2106 6559 PL79 1750 1325 0000 0000 3602 4167 PL96 1750 1325 0000 0000 3350 5547 PL54 1600 1462 1082 0783 7000 0006 |
| Patents | 1 active patent More › |
PKD codes:
72.11.Z - Research and experimental development on biotechnology
20.59.Z - Manufacture of other chemical products n.e.c.
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations
47.99.Z - Other retail sale not in stores, stalls or markets
71.20.A - Research and analysis related to food quality
71.20.B - Inspection and issuance of opinions on the technical condition of chimneys and ventilation ducts
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
QIAGEN GDAŃSK was established on 2023-09-01 and is currently located at UL. TRZY LIPY 3-2.58, PL-80-172, GDAŃSK. The main activity of the company is scientific research and development. Other activities carried out by the company include research and experimental development on biotechnology, manufacture of other chemical products n.e.c., manufacture of basic pharmaceutical products, manufacture of pharmaceutical preparations, other retail sale not in stores, stalls or markets and others. As per the latest entry in the National Court Register, the current management board of the company comprises 3 individual(s). The most recent update in the National Court Register was recorded on 2025-10-06.